Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties

Abstract excerpt

Inadequate control of the complement system is the underlying or aggravating factor in many human diseases. Whereas treatment options that specifically target the alternative pathway (AP) of complement activation are considered highly desirable, no such option is available in the clinic. In this study, we present a successful example of protein engineering, guided by structural insight on the complement regulator...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calcium signaling and nucleotide metabolism
• Share to Complement system in diseases
• Share to Platelet Disorders and Treatments